Genes Darwinian and Demographic Forces Affecting Human Protein Coding
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Efficacy and Mechanistic Evaluation of Tic10, a Novel Antitumor Agent
University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2012 Efficacy and Mechanisticv E aluation of Tic10, A Novel Antitumor Agent Joshua Edward Allen University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Oncology Commons Recommended Citation Allen, Joshua Edward, "Efficacy and Mechanisticv E aluation of Tic10, A Novel Antitumor Agent" (2012). Publicly Accessible Penn Dissertations. 488. https://repository.upenn.edu/edissertations/488 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/488 For more information, please contact [email protected]. Efficacy and Mechanisticv E aluation of Tic10, A Novel Antitumor Agent Abstract TNF-related apoptosis-inducing ligand (TRAIL; Apo2L) is an endogenous protein that selectively induces apoptosis in cancer cells and is a critical effector in the immune surveillance of cancer. Recombinant TRAIL and TRAIL-agonist antibodies are in clinical trials for the treatment of solid malignancies due to the cancer-specific cytotoxicity of TRAIL. Recombinant TRAIL has a short serum half-life and both recombinant TRAIL and TRAIL receptor agonist antibodies have a limited capacity to perfuse to tissue compartments such as the brain, limiting their efficacy in certain malignancies. To overcome such limitations, we searched for small molecules capable of inducing the TRAIL gene using a high throughput luciferase reporter gene assay. We selected TRAIL-inducing compound 10 (TIC10) for further study based on its induction of TRAIL at the cell surface and its promising therapeutic index. TIC10 is a potent, stable, and orally active antitumor agent that crosses the blood-brain barrier and transcriptionally induces TRAIL and TRAIL-mediated cell death in a p53-independent manner. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Recent Selection Changes in Human Genes Under Long-Term Balancing Selection Cesare De Filippo,*,1 Felix M
MBE Advance Access published March 10, 2016 Recent Selection Changes in Human Genes under Long-Term Balancing Selection Cesare de Filippo,*,1 Felix M. Key,1 Silvia Ghirotto,2 Andrea Benazzo,2 Juan R. Meneu,1 Antje Weihmann,1 NISC Comparative Sequence Program,3 Genı´s Parra,1 Eric D. Green,3 and Aida M. Andre´s*,1 1Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany 2Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy 3National Human Genome Research Institute, National Institutes of Health, Bethesda, MD *Corresponding author: E-mail: cesare_fi[email protected]; [email protected]. Associate editor: Ryan Hernandez Abstract Balancing selection is an important evolutionary force that maintains genetic and phenotypic diversity in populations. Most studies in humans have focused on long-standing balancing selection, which persists over long periods of time and is generally shared across populations. But balanced polymorphisms can also promote fast adaptation, especially when the Downloaded from environment changes. To better understand the role of previously balanced alleles in novel adaptations, we analyzed in detail four loci as case examples of this mechanism. These loci show hallmark signatures of long-term balancing selection in African populations, but not in Eurasian populations. The disparity between populations is due to changes in allele frequencies, with intermediate frequency alleles in Africans (likely due to balancing selection) segregating instead at low- or high-derived allele frequency in Eurasia. We explicitly tested the support for different evolutionary models with an http://mbe.oxfordjournals.org/ approximate Bayesian computation approach and show that the patterns in PKDREJ, SDR39U1,andZNF473 are best explained by recent changes in selective pressure in certain populations. -
Systematic Detection of Divergent Brain Proteins in Human Evolution and Their Roles in Cognition
bioRxiv preprint doi: https://doi.org/10.1101/658658; this version posted June 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Systematic detection of divergent brain proteins in human evolution and their roles in cognition Guillaume Dumas1,*, Simon Malesys1 and Thomas Bourgeron1 Affiliations: 1 Human Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, Université de Paris, Paris, (75015) France * Corresponding author: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/658658; this version posted June 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract The human brain differs from that of other primates, but the underlying genetic mechanisms remain unclear. Here we measured the evolutionary pressures acting on all human protein- coding genes (N=17,808) based on their divergence from early hominins such as Neanderthal, and non-human primates. We confirm that genes encoding brain-related proteins are among the most conserved of the human proteome. Conversely, several of the most divergent proteins in humans compared to other primates are associated with brain-associated diseases such as micro/macrocephaly, dyslexia, and autism. We identified specific eXpression profiles of a set of divergent genes in ciliated cells of the cerebellum, that might have contributed to the emergence of fine motor skills and social cognition in humans. -
The Interactome of KRAB Zinc Finger Proteins Reveals the Evolutionary History of Their Functional Diversification
Resource The interactome of KRAB zinc finger proteins reveals the evolutionary history of their functional diversification Pierre-Yves Helleboid1,†, Moritz Heusel2,†, Julien Duc1, Cécile Piot1, Christian W Thorball1, Andrea Coluccio1, Julien Pontis1, Michaël Imbeault1, Priscilla Turelli1, Ruedi Aebersold2,3,* & Didier Trono1,** Abstract years ago (MYA) (Imbeault et al, 2017). Their products harbor an N-terminal KRAB (Kru¨ppel-associated box) domain related to that of Krüppel-associated box (KRAB)-containing zinc finger proteins Meisetz (a.k.a. PRDM9), a protein that originated prior to the diver- (KZFPs) are encoded in the hundreds by the genomes of higher gence of chordates and echinoderms, and a C-terminal array of zinc vertebrates, and many act with the heterochromatin-inducing fingers (ZNF) with sequence-specific DNA-binding potential (Urru- KAP1 as repressors of transposable elements (TEs) during early tia, 2003; Birtle & Ponting, 2006; Imbeault et al, 2017). KZFP genes embryogenesis. Yet, their widespread expression in adult tissues multiplied by gene and segment duplication to count today more and enrichment at other genetic loci indicate additional roles. than 350 and 700 representatives in the human and mouse Here, we characterized the protein interactome of 101 of the ~350 genomes, respectively (Urrutia, 2003; Kauzlaric et al, 2017). A human KZFPs. Consistent with their targeting of TEs, most KZFPs majority of human KZFPs including all primate-restricted family conserved up to placental mammals essentially recruit KAP1 and members target sequences derived from TEs, that is, DNA trans- associated effectors. In contrast, a subset of more ancient KZFPs posons, ERVs (endogenous retroviruses), LINEs, SINEs (long and rather interacts with factors related to functions such as genome short interspersed nuclear elements, respectively), or SVAs (SINE- architecture or RNA processing. -
1 Mutational Heterogeneity in Cancer Akash Kumar a Dissertation
Mutational Heterogeneity in Cancer Akash Kumar A dissertation Submitted in partial fulfillment of requirements for the degree of Doctor of Philosophy University of Washington 2014 June 5 Reading Committee: Jay Shendure Pete Nelson Mary Claire King Program Authorized to Offer Degree: Genome Sciences 1 University of Washington ABSTRACT Mutational Heterogeneity in Cancer Akash Kumar Chair of the Supervisory Committee: Associate Professor Jay Shendure Department of Genome Sciences Somatic mutation plays a key role in the formation and progression of cancer. Differences in mutation patterns likely explain much of the heterogeneity seen in prognosis and treatment response among patients. Recent advances in massively parallel sequencing have greatly expanded our capability to investigate somatic mutation. Genomic profiling of tumor biopsies could guide the administration of targeted therapeutics on the basis of the tumor’s collection of mutations. Central to the success of this approach is the general applicability of targeted therapies to a patient’s entire tumor burden. This requires a better understanding of the genomic heterogeneity present both within individual tumors (intratumoral) and amongst tumors from the same patient (intrapatient). My dissertation is broadly organized around investigating mutational heterogeneity in cancer. Three projects are discussed in detail: analysis of (1) interpatient and (2) intrapatient heterogeneity in men with disseminated prostate cancer, and (3) investigation of regional intratumoral heterogeneity in -
Supplementary Note
1 SUPPLEMENTARY NOTE 2 Table of Contents 3 1 Studies contributing to systolic (SBP) and diastolic blood pressure (DBP) analyses ............ 4 4 2 Consortia and studies providing association results for cardiovascular outcomes ............. 4 5 2.1 CHARGE - Heart Failure Working Group .................................................................................. 4 6 2.2 EchoGen (LM mass and LV weight) .......................................................................................... 4 7 2.3 NEURO-CHARGE (stroke) ........................................................................................................ 4 8 2.4 MetaStroke (stroke) ................................................................................................................ 5 9 2.5 CARDIoGRAMplusC4D (CAD) ................................................................................................... 5 10 2.6 CHARGE CKDgen (CKD, eGFR, microalbuminuria, UACR) ......................................................... 5 11 2.7 KidneyGen (creatinine) ........................................................................................................... 6 12 2.8 CHARGE (cIMT) ....................................................................................................................... 6 13 2.9 CHARGE (mild retinopathy, central retinal artery caliber) ....................................................... 6 14 2.10 SEED (mild retinopathy, central retinal artery caliber) .......................................................... 6 15 -
Research Article Clinic-Genomic Association Mining for Colorectal Cancer Using Publicly Available Datasets
Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 170289, 10 pages http://dx.doi.org/10.1155/2014/170289 Research Article Clinic-Genomic Association Mining for Colorectal Cancer Using Publicly Available Datasets Fang Liu,1 Yaning Feng,1 Zhenye Li,2 Chao Pan,1 Yuncong Su,1 Rui Yang,1 Liying Song,1 Huilong Duan,1 and Ning Deng1 1 Department of Biomedical Engineering, Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou 310027, China 2 General Hospital of Ningxia Medical University, Yinchuan 750004, China Correspondence should be addressed to Ning Deng; [email protected] Received 30 March 2014; Accepted 12 May 2014; Published 2 June 2014 Academic Editor: Degui Zhi Copyright © 2014 Fang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In recent years, a growing number of researchers began to focus on how to establish associations between clinical and genomic data. However, up to now, there is lack of research mining clinic-genomic associations by comprehensively analysing available gene expression data for a single disease. Colorectal cancer is one of the malignant tumours. A number of genetic syndromes have been proven to be associated with colorectal cancer. This paper presents our research on mining clinic-genomic associations for colorectal cancer under biomedical big data environment. The proposed method is engineered with multiple technologies, including extracting clinical concepts using the unified medical language system (UMLS), extracting genes through the literature mining, and mining clinic-genomic associations through statistical analysis. -
Exome Sequencing Identifies a Spectrum of Mutation Frequencies in Advanced and Lethal Prostate Cancers
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers Akash Kumara, Thomas A. Whiteb, Alexandra P. MacKenziea, Nigel Cleggb, Choli Leea, Ruth F. Dumpitb, Ilsa Colemanb, Sarah B. Nga, Stephen J. Salipantea, Mark J. Riedera, Deborah A. Nickersona, Eva Coreyc, Paul H. Langec, Colm Morrisseyc, Robert L. Vessellac, Peter S. Nelsona,b,c,1, and Jay Shendurea,1 aDepartment of Genome Sciences, University of Washington, Seattle, WA 98105; bFred Hutchinson Cancer Research Center, Seattle, WA 98109; and cDepartment of Urology, University of Washington, Seattle, WA 98195 Edited* by Mark Groudine, Fred Hutchinson Cancer Research Center, Seattle, WA, and approved September 1, 2011 (received for review June 4, 2011) To catalog protein-altering mutations that may drive the de- lethality that exists in prostate cancer. Furthermore, these tumor velopment of prostate cancers and their progression to metastatic xenografts have the advantage of little to no human stromal disease systematically, we performed whole-exome sequencing of contamination and provide the means to test the consequences 23 prostate cancers derived from 16 different lethal metastatic of mutations functionally. Although corresponding normal tissue tumors and three high-grade primary carcinomas. All tumors were was not sequenced for most samples, we find that comparisons propagated in mice as xenografts, designated the LuCaP series, to with increasingly deep catalogs of segregating germline variants fi model phenotypic variation, such as responses -
Copyright by Akshay Anant Bhinge 2009
Copyright by Akshay Anant Bhinge 2009 The Dissertation Committee for Akshay Anant Bhinge Certifies that this is the approved version of the following dissertation: A Functional Genomics Approach To Map Transcriptional and Post- transcriptional Gene Regulatory Networks Committee: Vishwanath Iyer, Supervisor Makkuni Jayaram Krishnendu Roy Scott Stevens Christopher Sullivan A Functional Genomics Approach To Map Transcriptional and Post- transcriptional Gene Regulatory Networks by Akshay Anant Bhinge, M.B.B.S.; M.Tech. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2009 Dedication I dedicate this work to my parents who, against great odds, gave me the opportunity to pursue my goals and to Seema, my best friend and the love of my life. Acknowledgements I would like to thank my advisor Dr. Vishwanath Iyer for his incredible patience as he mentored me throughout graduate school. He always made it a priority to make himself available to his students. Every project idea, however wacky, that I have presented to him was granted serious thought and critical comments. Without his constant encouragement, I would not have made it this far. I would also like to thank my committee members for their insightful and helpful suggestions. To my family, I am very grateful. I would not have been able to pursue graduate studies without my parent’s unwavering support or my brother’s motivation. I want to thank Yogish for sparking my interest in science. -
Histone Methyltransferase KMT2D Sustains Prostate Carcinogenesis and Metastasis Via Epigenetically Activating LIFR and KLF4
Oncogene (2018) 37:1354–1368 https://doi.org/10.1038/s41388-017-0026-x ARTICLE Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4 1,2 2 3 2 1 2 2 2 Shidong Lv ● Liyan Ji ● Bin Chen ● Shuqiang Liu ● Chengyong Lei ● Xi Liu ● Xiaoxiao Qi ● Ying Wang ● 4 1 1 1 2,4 1 2,4 Elaine Lai-Han Leung ● Hongyi Wang ● Lin Zhang ● Xiaoming Yu ● Zhongqiu Liu ● Qiang Wei ● Linlin Lu Received: 26 May 2017 / Revised: 14 October 2017 / Accepted: 19 October 2017 / Published online: 22 December 2017 © The Author(s) 2018. This article is published with open access Abstract Abnormalities in epigenetic modifiers are emerging as driving events in prostate cancer (PCa). The histone methyltransferase KMT2D, a frequently aberrant epigenetic modifier in various tumors, has an undefined role in PCa. Moreover, little is known regarding KMT2D’s mutation in Chinese patients or its downstream signaling pathways and targets. Here, we profiled the mutational spectrum of 32 significantly PCa-associated genes by using disease-targeted sequencing, and found that KMT2D was highly mutated (63.04%, 29/46) in Chinese patients. Moreover, high KMT2D transcription was also associated with poor prognosis in an independent cohort (n = 51). In KMT2D-knockdown PC-3 and DU145 cells, cell P < P < P < 1234567890 proliferation ( 0.01), invasion ( 0.001), and migration ( 0.01) were consequently suppressed. KMT2D depletion effectively suppressed tumor growth by 92.21% in vivo. Notably, integrative analyses of RNAseq and ChIPseq characterized two crucial genes downregulated by KMT2D, leukemia inhibitory factor receptor (LIFR) and Kruppel-like factor-4 (KLF4), which are regulators in PI3K/Akt and EMT, respectively. -
Comprehensive Analysis Reveals Novel Gene Signature in Head and Neck Squamous Cell Carcinoma: Predicting Is Associated with Poor Prognosis in Patients
5892 Original Article Comprehensive analysis reveals novel gene signature in head and neck squamous cell carcinoma: predicting is associated with poor prognosis in patients Yixin Sun1,2#, Quan Zhang1,2#, Lanlin Yao2#, Shuai Wang3, Zhiming Zhang1,2 1Department of Breast Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; 2School of Medicine, Xiamen University, Xiamen, China; 3State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China Contributions: (I) Conception and design: Y Sun, Q Zhang; (II) Administrative support: Z Zhang; (III) Provision of study materials or patients: Y Sun, Q Zhang; (IV) Collection and assembly of data: Y Sun, L Yao; (V) Data analysis and interpretation: Y Sun, S Wang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Zhiming Zhang. Department of Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China. Email: [email protected]. Background: Head and neck squamous cell carcinoma (HNSC) remains an important public health problem, with classic risk factors being smoking and excessive alcohol consumption and usually has a poor prognosis. Therefore, it is important to explore the underlying mechanisms of tumorigenesis and screen the genes and pathways identified from such studies and their role in pathogenesis. The purpose of this study was to identify genes or signal pathways associated with the development of HNSC. Methods: In this study, we downloaded gene expression profiles of GSE53819 from the Gene Expression Omnibus (GEO) database, including 18 HNSC tissues and 18 normal tissues.